ABSTRACT
Raphael M. Ottenbrite Virginia Commonwealth University, Richmond, Virginia
Yasuo Suda Osaka University, Osaka, Japan
I. INTRODUCTION
Since the pioneer work by Merigan in 1967 [l], many kinds of synthetic or natural polyanionic polymers have been examined for their biological activities [2-8], such as cytotoxicity, antiviral activity, antitumor activity, and immunomodulating activity. Although the biological results were interesting, the extent of activity for clinical application was still low.